Jubilant gets US FDA nod for anti-depressant drug

Bangalore, Oct 18 : Leading pharma firm Jubilant Life Sciences received approval from the US Food and Drug Administration (FDA) for its anti-depressant drug Bupropion Hydrochloride, the company said Friday.

"We have also received approval for the same extended drug used as smoking cessation aid. Both formulations are generic version of GlaxoSmithKline's Wellbutrin and Zyban tablets respectively," the company said in a statement here.

The market size for the twin products is estimated to be around USD 518 million annually.

"We propose to launch both the drugs in this quarter of 2013-14," the statement said.

The company has filed 649 applications for formulations till June, of which 189 were approved in different geographies the world over, including 58 abbreviated new drug application (ANDA) in the US and 41 dossier filings in Europe.

With 10 production facilities across India, Canada and the US, Jubilant manufactures and supplies active pharmaceutical ingredients (APIs), generics, specialty pharmaceuticals and life science ingredients, besides providing services in contract manufacturing and drug discovery and development.

--IANS (Posted on 18-10-2013)

pharmaceutical-news headlines

Sanofi appoints N Rajaram as Country Head & GM (Pharma operations)

Nutraceuticals slams FSSAI 'Product Approval' scheme

Some facts about drug over which Powell banned

Lupin gets USFDA nod for diabetes management drug

Sun Pharma to acquire Ranbaxy for USD four billion in all stock transaction

Sun Pharma to buy Ranbaxy for $4 billion in all-share deal

Venus gets marketing nod from Venezuela for meropenem

Venus gets marketing nod from Venezuela for infection drug

Jubilant Life to develop new drugs to combat TB

Jubilant gets $3.4 mn for new anti-TB drugs

Prolonged crisis in Ukraine could affect Indian pharma companies

Strand receives US patent for virtual liver

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014


Your e-mail:

Your Full Name:

Type verification image:
verification image, type it in the box


Back to Top